menu

Meningococcal Meningitis Treatment Market

Schedule Call

Meningococcal Meningitis Treatment Market

Meningococcal Meningitis Treatment Market by Treatment Type (Antibiotic Therapy, Vaccine), Route of Administration (Injectable, Oral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies)- Global Outlook and Forecast 2023-2031

GR - 509067 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: April 10, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023-2031


Meningococcal Meningitis Treatment Market Scope

Report Attribute

Details

Market Size Value in 2022

US$ 4.22 Billion

Revenue Forecast in 2031

US$ 12.24 Billion

CAGR

12.56%

Base Year For Estimation

2022

Forecast Period

2023 to 2031

Historical Year

2021

Segments Covered

Treatment Type, Route of Administration, End User, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global meningococcal meningitis treatment market was valued at US$ 4.22 Billion in 2022 and is expected to register a revenue CAGR of 12.56% to reach US$ 12.24 Billion by 2031.

Meningococcal Meningitis Treatment Market Fundamentals

Meningococcal meningitis is a disease caused by the bacteria Neisseria meningitidis. These diseases are frequently severe, can be fatal, and include infections of the brain and spinal cord lining (meningitis) and circulation. The best defense against meningococcal disease is immunization. Meningococcal meningitis symptoms include fever, headache, stiff neck, and a rash. 

The global meningococcal meningitis treatment market revenue is expected to increase gradually during the forecast period. One of the key factors of market revenue expansion is the increasing prevalence of meningococcal meningitis globally. According to the World Health Organization (WHO), meningococcal meningitis is the primary cause of bacterial meningitis worldwide, with around 1.2 million cases reported annually. Furthermore, the availability of new and improved treatments is expected to fuel market revenue expansion. Pharmaceutical companies are substantially investing in researching new antibiotics and vaccines to prevent meningococcal meningitis, which is expected to boost market revenue expansion further. 

Increased disease awareness and the availability of sophisticated diagnostic techniques are also expected to fuel the market revenue growth. Furthermore, increased government measures to restrict the spread of meningococcal meningitis through vaccination programs and public awareness campaigns are also expected to drive market revenue share during the forecast period.

[7686]

Meningococcal Meningitis Treatment Market Dynamics 

The increasing prevalence of meningococcal meningitis is the prominent factor driving the revenue growth of the global meningococcal meningitis treatment market.  According to the National Library of Medicine, the global incidence of meningitis is estimated to be 20 per 100,000 people, or approximately 1.2 million; the incidence and causes vary by geographic region. Most epidemics occur in Sub-Saharan Africa. The epidemic of meningococcal meningitis infections in Africa, New Zealand, and Singapore suggests that the infection remains a serious public health issue or a global outbreak. Meningococcal disease can affect anyone; however, the condition is most common in children under the age of one, with a second peak in puberty. Meningococcal meningitis disease is more common in teenagers and young adults aged 16 to 23.

One of the potential trends increasing the global meningococcal meningitis treatment market revenue is the increasing investments by top players in the treatment of meningococcal meningitis. This is due to the disease's high fatality rate and possible outbreaks, particularly in underdeveloped nations with inadequate access to vaccines and healthcare. New therapies and vaccines are significant in controlling the spread of meningococcal meningitis and lowering its worldwide effect. In April 2020, Sanofi Pasteur, Inc. announced the FDA approval of biologics MenQuadfi meningococcal (Groups A, C, Y, W) conjugate vaccine to prevent invasive meningococcal disease in 2 years and older. The approval of this new vaccination in the United States marks a major step forward in the ongoing effort to protect people from meningococcal meningitis.

Collaborations among pharmaceutical companies and non-profit global health organizations are expected to increase the accessibility of vaccines in low-income nations such as Africa. For instance, WHO and PATH collaborated on the Meningitis Vaccine Project. It was founded in 2001 with primary funding provided by the Bill & Melinda Gates Foundation. This collaboration aims to create a vaccine at a low enough cost that it can be used widely across Africa. This was done to ensure that epidemics like the one that killed 25,000 people in 1996-97 would never recur again. Manufacturers in developed countries could not create the vaccine at such a low cost. Instead, the consortium conducted the research. The vaccine was then manufactured at the Serum Institute of India. Currently, NmCV-5 is in phase 3 of clinical trials. The vaccines are considered safe, well-tolerated, and capable of eliciting robust immunological responses against all five serogroups. 

However, the high cost of treatment is limiting the revenue growth of the global meningococcal meningitis treatment market. Additionally, a lack of awareness about the disease and its treatment & diagnosis among people in developing countries is also impeding the revenue growth of the global meningococcal meningitis treatment market. 

Meningococcal Meningitis Treatment Market Ecosystem

The global meningococcal meningitis treatment market is analyzed from four perspectives: treatment type, route of administration, end-user, and region.

Meningococcal Meningitis Treatment Market by Treatment Type

[96786] 

Based on treatment type, the global meningococcal meningitis treatment market is segmented into antibiotic therapy and vaccine. 

The vaccine segment dominated the global meningococcal meningitis treatment market with the largest revenue share in 2022. The vaccine segment is further sub-segmented into a meningococcal conjugate vaccine, meningococcal polysaccharide vaccine, and combination vaccine. Meningococcal meningitis vaccination is the most effective strategy to reduce the disease's burden and effects by providing long-term protection. The growing public awareness of the necessity of vaccination and government measures to encourage immunization programs are expected to drive the expansion of the meningococcal meningitis treatment market revenue during the forecast period. Moreover, the meningococcal meningitis treatment market revenue growth is expected to be supported by the discovery of novel vaccines with enhanced efficacy and safety characteristics. 

However, the antibiotic therapy segment is expected to increase its revenue share during the forecast period. The antibiotic segment is sub-segmented into penicillin, ampicillin, chloramphenicol, and ceftriaxone.  This increase can be attributed to the rising prevalence of infectious diseases as well as the increased demand for efficient antibiotics. The development of novel and enhanced antibiotics is expected to aid in expanding the antibiotic segment. Furthermore, rising government initiatives for developing healthcare infrastructure and expanding public awareness about the need for early detection and treatment of infectious diseases are expected to increase the demand for antibiotic therapy. Because of the high prevalence of infectious diseases and the presence of a big patient pool, the Asia Pacific region is expected to see significant growth in market revenue.

Meningococcal Meningitis Treatment Market by Route of Administration

Based on the route of administration, the global meningococcal meningitis treatment market is segmented into injectables and oral. 

Injectables dominated the global meningococcal meningitis treatment market with the highest revenue share in 2022. The segment is expected to continue its dominance during the forecast period due to its high efficacy and quick onset of action. Injectable antibiotics can quickly reach therapeutic levels in the bloodstream, effectively treating meningococcal meningitis. Additionally, injectables allow for precise dosing and can be administered in a hospital or outpatient setting. Moreover, the rising demand for combination vaccines and the development of novel vaccines with improved efficacy and safety profiles are expected to fuel market revenue growth.

Meningococcal Meningitis Treatment Market by Distribution Channel

Based on the distribution channel, the global meningococcal meningitis treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. 

The hospital pharmacies segment accounts for the majority of the global meningococcal meningitis treatment market revenue share. This significant share of revenue can be attributed to hospital pharmacies being the primary point of care for patients suffering from meningococcal meningitis. Additionally, hospital pharmacies often have a wider range of medications and resources than retail or online pharmacies. Furthermore, hospital pharmacies employ qualified personnel to make individualized medicine and dosage recommendations depending on the patient's condition and medical history. This ensures that patients receive the best therapy possible for their meningococcal meningitis, which can improve their chances of recovery.

Meningococcal Meningitis Treatment Market by Region

Based on the region, the global meningococcal meningitis treatment market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.

North America accounts for the majority of the global meningococcal meningitis treatment market revenue share. The prevalence of meningococcal meningitis acts as the key factor in increasing North America's meningococcal meningitis treatment market. In the United States, the annual incidence is 1.33 cases per 100,000 people. Furthermore, North America's modern healthcare infrastructure and advantageous reimbursement policies assist the region's revenue growth in the meningococcal meningitis treatment market.

During the forecast period, it is expected that the meningococcal meningitis treatment market in Europe will expand due to the region's favorable medical policies and strong healthcare infrastructure. In addition, government initiatives and healthcare policies focused on minimizing the prevalence of meningococcal meningitis are also fueling market revenue expansion. Routine vaccination against meningococcal meningitis is now included in certain nations' national immunization programs. 

Asia Pacific is expected to be the fastest-growing geographic region in terms of revenue share in the global meningococcal meningitis treatment market during the forecast period. This sizable share of revenue is attributed to the increasing prevalence of meningococcal meningitis in the region and the rising demand for effective treatment options. The development of advanced healthcare infrastructure and the growing awareness about the disease is also expected to contribute to market revenue growth. Furthermore, the presence of key market players in the region and the ongoing research and development activities for developing new treatment options are expected to drive market revenue growth in the Asia Pacific. 

Competitive Landscape of the Global Meningococcal Meningitis Treatment Market

The meningococcal meningitis treatment market is highly competitive due to the presence of several established players and the emergence of new entrants. The increasing prevalence of meningococcal meningitis worldwide has led to a surge in demand for effective treatments, further intensifying the competition in the market. 

The prominent companies operating in the global meningococcal meningitis treatment market with the largest revenue share are:

Strategic Developments in Meningococcal Meningitis Treatment Market

  • In May 2022, GlaxoSmithKline announced a USD 3.3 billion acquisition of privately held biopharmaceutical firm Affinivax to support its vaccination pipeline, a crucial focus as the British drugmaker prepares to split off its consumer unit.
  • In March 2022, the University of Maryland School of Medicine (UMSOM) led studies evaluating the meningococcal vaccine for African newborns and young children. 

Frequently Asked Questions About This Report

The vaccine segment has the largest revenue share in the global meningococcal meningitis treatment market.

The global meningococcal meningitis treatment market is expected to grow at a revenue CAGR of 12.56% during the forecast period.

Baxter International Inc., Merck & Co., Medtronic Inc., and Sanofi SA are a few key players operating in the global meningococcal meningitis treatment market.

During the forecast period, the Asia Pacific region is expected to observe the highest global meningococcal meningitis treatment market revenue growth.

The high cost of treatment and lack of awareness can limit the revenue growth of the global meningococcal meningitis treatment market.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET - ANALYSIS & FORECAST, BY TREATMENT TYPE
    1. Antibiotic Therapy
      1. Penicillin
      2. Ampicillin
      3. Chloramphenicol
      4. Ceftriaxone
    2. Vaccine
      1. Meningococcal Conjugate Vaccine
      2. Meningococcal Polysaccharide Vaccine
      3. Combination Vaccine
  6. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Injectables
    2. Oral
  7. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL 
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  8. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Meningococcal Meningitis Treatment Market
      1. North America Meningococcal Meningitis Treatment Market, By Treatment Type
      2. North America Meningococcal Meningitis Treatment Market, By Route of Administration
      3. North America Meningococcal Meningitis Treatment Market, By Distribution Channel
      4. North America Meningococcal Meningitis Treatment Market, By Country
        1. U.S.
          1. U.S. Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. U.S. Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. U.S. Meningococcal Meningitis Treatment Market, By Distribution Channel 
        2. Canada
          1. Canada Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Canada Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Canada Meningococcal Meningitis Treatment Market, By Distribution Channel  
    2. Europe Meningococcal Meningitis Treatment Market
      1. Europe Meningococcal Meningitis Treatment Market, By Treatment Type 
      2. Europe Meningococcal Meningitis Treatment Market, By Route of Administration
      3. Europe Meningococcal Meningitis Treatment Market, By Distribution Channel 
      4. Europe Meningococcal Meningitis Treatment Market, By Country/Region
        1. Germany
          1. Germany Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Germany Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. Germany Meningococcal Meningitis Treatment Market, By Distribution Channel 
        2. U.K.
          1. U.K. Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. U.K. Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. U.K. Meningococcal Meningitis Treatment Market, By Distribution Channel 
        3. France
          1. France Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. France Meningococcal Meningitis Treatment Market, By Route of Administration
          3. France Meningococcal Meningitis Treatment Market, By Distribution Channel 
        4. Spain
          1. Spain Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Spain Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Spain Meningococcal Meningitis Treatment Market, By Distribution Channel             
        5. Italy
          1. Italy Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Italy Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Italy Meningococcal Meningitis Treatment Market, By Distribution Channel             
        6. Rest of Europe 
          1. Rest of Europe Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Rest of Europe Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. Rest of Europe Meningococcal Meningitis Treatment Market, By Distribution Channel
    3. Asia Pacific Meningococcal Meningitis Treatment Market
      1. Asia Pacific Meningococcal Meningitis Treatment Market, By Treatment Type 
      2. Asia Pacific Meningococcal Meningitis Treatment Market, By Route of Administration  
      3. Asia Pacific Meningococcal Meningitis Treatment Market, By Distribution Channel  
      4. Asia Pacific Meningococcal Meningitis Treatment Market, By Country/Region
        1. China
          1. China Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. China Meningococcal Meningitis Treatment Market, By Route of Administration
          3.  China Meningococcal Meningitis Treatment Market, By Distribution Channel   
        2. Japan
          1. Japan Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Japan Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Japan Meningococcal Meningitis Treatment Market, By Distribution Channel  
        3. India
          1. India Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. India Meningococcal Meningitis Treatment Market, By Route of Administration
          3. India Meningococcal Meningitis Treatment Market, By Distribution Channel             
        4. South Korea
          1. South Korea Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. South Korea Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. South Korea Meningococcal Meningitis Treatment Market, By Distribution Channel 
        5. Australia
          1. Australia Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Australia Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. Australia Meningococcal Meningitis Treatment Market, By Distribution Channel 
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Distribution Channel     
    4. Latin America Meningococcal Meningitis Treatment Market
      1. Latin America Meningococcal Meningitis Treatment Market, By Treatment Type 
      2. Latin America Meningococcal Meningitis Treatment Market, By Route of Administration
      3. Latin America Meningococcal Meningitis Treatment Market, By Distribution Channel 
      4. Latin America Meningococcal Meningitis Treatment Market, By Country/Region
        1. Brazil
          1. Brazil Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Brazil Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Brazil Meningococcal Meningitis Treatment Market, By Distribution Channel 
        2. Mexico
          1. Mexico Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Mexico Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. Mexico Meningococcal Meningitis Treatment Market, By Distribution Channel              
        3. Argentina
          1. Argentina Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Argentina Meningococcal Meningitis Treatment Market, By Route of Administration
          3. Argentina Meningococcal Meningitis Treatment Market, By Distribution Channel 
        4. Rest of Latin America
          1. Rest of Latin America Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Rest of Latin America Meningococcal Meningitis Treatment Market, By Route of Administration           
          3. Rest of Latin America Meningococcal Meningitis Treatment Market, By Distribution Channel      
    5. Middle East & Africa Meningococcal Meningitis Treatment Market
      1. Middle East & Africa Meningococcal Meningitis Treatment Market, By Treatment Type 
      2. Middle East & Africa Meningococcal Meningitis Treatment Market, By Route of Administration 
      3. Middle East & Africa Meningococcal Meningitis Treatment Market, By Distribution Channel                      
      4. Middle East & Africa a Meningococcal Meningitis Treatment Market, By Country/Region
        1. GCC Countries
          1. GCC Countries Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. GCC Countries Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. GCC Countries Meningococcal Meningitis Treatment Market, By Distribution Channel                 
        2. South Africa
          1. South Africa Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. South Africa Meningococcal Meningitis Treatment Market, By Route of Administration 
          3. South Africa Countries Meningococcal Meningitis Treatment Market, By Distribution Channel                  
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Treatment Type 
          2. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Route of Administration                
          3. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Distribution Channel 
  9. COMPANY PROFILES         
    1. Biomed Pvt. Ltd  
      1. Business Snapshot 
      2. Products Offered
      3. Financial Details
      4. Strategic Development
    2. Novartis AG
    3. Pfizer, Inc. 
    4. Baxter International Inc. 
    5. Merck & Co.
    6. Medtronic Inc.
    7. Sanofi SA
    8.  GlaxoSmithKline Plc.
    9.  F. Hoffmann-La Roche Ltd.
    10. Wockhardt Ltd.

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

 

  1. Global Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion)
  2. Global Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  3. Global Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  4. Global Meningococcal Meningitis Treatment Market, By Region, 2021-2031 (US$ Billion) 
  5. North America Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion)
  6. North America Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  7. North America Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  8. North America Meningococcal Meningitis Treatment Market, By Country, 2021-2031 (US$ Billion) 
  9. U.S. Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  10. U.S. Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  11. U.S. Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion)
  12. Canada Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  13. Canada Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  14. Canada Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  15. Europe Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  16. Europe Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  17. Europe Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  18. Europe Meningococcal Meningitis Treatment Market, By Country/Region, 2021-2031 (US$ Billion) 
  19. Germany Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  20. Germany Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  21. Germany Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  22. U.K. Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  23. U.K. Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  24. U.K. Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  25. France Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  26. France Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  27. France Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  28. Italy Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  29. Italy Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  30. Italy Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  31. Spain Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  32. Spain Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  33. Spain Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  34. Rest of Europe Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  35. Rest of Europe Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  36. Rest of Europe Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  37. Asia Pacific Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  38. Asia Pacific Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  39. Asia Pacific Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  40. Asia Pacific Meningococcal Meningitis Treatment Market, By Country/Region, 2021-2031 (US$ Billion) 
  41. China Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  42. China Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  43. China Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  44. Japan Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  45. Japan Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  46. Japan Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  47. India Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  48. India Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  49. India Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  50. South Korea Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  51. South Korea Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  52. South Korea Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  53. Australia Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  54. Australia Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  55. Australia Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  56. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  57. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  58. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  59. Latin America Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  60. Latin America Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  61. Latin America Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  62. Latin America Meningococcal Meningitis Treatment Market, By Country/Region, 2021–2031 (US$ Billion)
  63. Brazil Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  64. Brazil Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  65. Brazil Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  66. Mexico Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  67. Mexico Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  68. Mexico Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  69. Argentina Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  70. Argentina Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  71. Argentina Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  72. Rest of Latin America Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  73. Rest of Latin America Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  74. Rest of Latin America Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  75. Middle East and Africa Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  76. Middle East and Africa Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  77. Middle East and Africa Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  78. Middle East and Africa Meningococcal Meningitis Treatment Market, By Country/Region, 2021–2031 (US$ Billion)
  79. GCC Countries Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  80. GCC Countries Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  81. GCC Countries Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  82. South Africa Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  83. South Africa Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  84. South Africa Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 
  85. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Treatment Type, 2021-2031 (US$ Billion) 
  86. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Route of Administration, 2021–2031 (US$ Billion) 
  87. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, By Distribution Channel, 2021–2031 (US$ Billion) 

List of Figures

  1. Meningococcal Meningitis Treatment Market Ecosystem  
  2. Snapshot of Global Meningococcal Meningitis Treatment Market, 2021-2031 
  3. Snapshot of Global Meningococcal Meningitis Treatment Market, By Region, 2021-2031 
  4. Global Meningococcal Meningitis Treatment Market: COVID-19 Pandemic Impact Assessment 
  5. Global Meningococcal Meningitis Treatment Market: Key Players & Competitive Positioning (2021) 
  6. Meningococcal Meningitis Treatment: Market Dynamics 
  7. Global Meningococcal Meningitis Treatment Market, for Antibiotic Therapy, 2021-2031 (US$ Billion) 
  8. Global Meningococcal Meningitis Treatment Market for Penicillin, 2021-2031 (US$ Billion) 
  9. Global Meningococcal Meningitis Treatment Market for Ampicillin, 2021-2031 (US$ Billion) 
  10. Global Meningococcal Meningitis Treatment Market for Chloramphenicol, 2021-2031 (US$ Billion) 
  11. Global Meningococcal Meningitis Treatment Market for Ceftriaxone, 2021-2031 (US$ Billion) 
  12. Global Meningococcal Meningitis Treatment Market for Vaccine, 2021-2031 (US$ Billion)
  13. Global Meningococcal Meningitis Treatment Market for Meningococcal Conjugate Vaccine, 2021-2031 (US$ Billion) 
  14. Global Meningococcal Meningitis Treatment Market for Meningococcal Polysaccharide Vaccine, 2021-2031 (US$ Billion)
  15. Global Meningococcal Meningitis Treatment Market for Combination Vaccine, 2021-2031 (US$ Billion)
  16. Global Meningococcal Meningitis Treatment Market for Injectables, 2021-2031 (US$ Billion)
  17. Global Meningococcal Meningitis Treatment Market for Oral, 2021-2031 (US$ Billion)
  18. Global Meningococcal Meningitis Treatment Market for Hospital Pharmacies, 2021-2031 (US$ Billion)
  19. Global Meningococcal Meningitis Treatment Market for Retail Pharmacies, 2021-2031 (US$ Billion)
  20. Global Meningococcal Meningitis Treatment Market for Online Pharmacies, 2021-2031 (US$ Billion)
  21. North America Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  22. U.S. Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  23. Canada Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  24. Europe Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  25. Germany Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  26. U.K. Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  27. France Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  28. Italy Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  29. Spain Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  30. Rest of Europe Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  31. Asia Pacific Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  32. China Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  33. Japan Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  34. India Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  35. South Korea Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  36. Australia Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  37. Rest of Asia Pacific Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  38. Latin America Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  39. Brazil Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  40. Mexico Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  41. Argentina Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion)
  42. Rest of Latin America Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion)
  43. Middle East & Africa Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  44. GCC Countries Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  45. South Africa Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion) 
  46. Rest of Middle East & Africa Meningococcal Meningitis Treatment Market, 2021-2031 (US$ Billion)
  47. Biomed Pvt. Ltd Revenue from 2019 Onwards (US$ Billion)
  48. Novartis AG, Revenue from 2019 Onwards (US$ Billion)
  49. Pfizer, Inc.  Revenue from 2019 Onwards (US$ Billion)
  50. Baxter International Inc. Revenue from 2019 Onwards (US$ Billion)
  51. Merck & Co. Revenue from 2019 Onwards (US$ Billion)
  52. Sanofi SA Revenue from 2019 Onwards (US$ Billion)
  53. GlaxoSmithKline Plc. Revenue from 2019 Onwards (US$ Billion)
  54. F. Hoffmann-La Roche Ltd. Revenue from 2019 Onwards (US$ Billion)
  55. Wockhardt Ltd. Revenue from 2019 Onwards (US$ Billion)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Meningococcal Meningitis Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Meningococcal Meningitis Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports